• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者信息咨询小组与可识别患者的数据的使用。

The Patient Information Advisory Group and the use of patient-identifiable data.

作者信息

Higgins Joan

机构信息

Manchester Centre for Healthcare Management, University of Manchester, UK.

出版信息

J Health Serv Res Policy. 2003 Jul;8 Suppl 1:S1:8-11. doi: 10.1258/135581903766468819.

DOI:10.1258/135581903766468819
PMID:12869331
Abstract

Patient confidentiality has been a matter of concern in the English National Health Service (NHS) for many years. A number of recent events have triggered the demand for a more concerted programme of change to eliminate the use of patient-identifiable data and to devise more acceptable alternatives. The Caldicott Committee, in 1997, set out the case for change and legislation in 1998 (the Data Protection Act and Human Rights Act) and emphasised the need for urgent action. A number of public inquiries into failures of care in the NHS (at Bristol Royal Infirmary and Alder Hey Hospital) pointed to the failure to seek consent as a major issue for the NHS. Whilst accepting the need for change, the Government, in drafting the Health and Social Care Act 2001, allowed for the fact that some organisations and individuals would need time to move towards anonymisation of data (reversible or irreversible) or to obtain patient consent. Under Section 60 of the Act it established the Patient Information Advisory Group (PIAG). PIAG advises government ministers on circumstances in which the continued use of patient-identifiable data should be permitted, as a temporary measure. PIAG faces a number of challenges as it develops its programme of work: how to maintain the pace of change towards anonymisation, how to ensure compliance with the law, how or whether to share information across organisational boundaries in the interests of citizens, how consent should be obtained and how to achieve 'joined up' working across those organisations that are charged with promoting confidentiality and privacy.

摘要

多年来,患者保密问题一直是英国国民医疗服务体系(NHS)关注的焦点。近期的一系列事件引发了对更协调一致的变革计划的需求,以消除使用可识别患者身份的数据,并设计出更可接受的替代方案。1997年,卡尔迪科特委员会阐述了变革的理由,1998年出台了相关立法(《数据保护法》和《人权法》),并强调了采取紧急行动的必要性。对NHS医疗失误的多项公开调查(如布里斯托尔皇家医院和奥尔德希儿童医院)指出,未寻求患者同意是NHS的一个主要问题。政府在起草2001年《健康与社会保健法》时,虽然承认有变革的必要,但也考虑到一些组织和个人需要时间来实现数据匿名化(可逆或不可逆)或获得患者同意。根据该法案第60条,政府设立了患者信息咨询小组(PIAG)。PIAG就作为临时措施允许继续使用可识别患者身份数据的情况向政府部长提供建议。PIAG在制定其工作计划时面临诸多挑战:如何保持向匿名化转变的速度,如何确保遵守法律,如何或是否为了公民利益跨组织边界共享信息,如何获得同意,以及如何在负责促进保密和隐私的那些组织之间实现“联合”工作。

相似文献

1
The Patient Information Advisory Group and the use of patient-identifiable data.患者信息咨询小组与可识别患者的数据的使用。
J Health Serv Res Policy. 2003 Jul;8 Suppl 1:S1:8-11. doi: 10.1258/135581903766468819.
2
Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.在未获得知情同意的情况下使用常规收集的可识别健康信息进行的低风险研究:与患者信息咨询小组的接触
J Med Ethics. 2008 Jan;34(1):37-40. doi: 10.1136/jme.2006.019661.
3
Privacy and the secondary use of data in health research in Scotland.苏格兰健康研究中的隐私与数据二次使用
J Health Serv Res Policy. 2003 Jul;8 Suppl 1:S1:12-6. doi: 10.1258/135581903766468828.
4
Issues of patient consent: a study of paediatric high-dependency care.患者同意问题:一项关于儿科重症监护的研究。
Br J Nurs. 2005;14(9):519-23. doi: 10.12968/bjon.2005.14.9.18079.
5
Legal and ethical considerations in processing patient-identifiable data without patient consent: lessons learnt from developing a disease register.在未经患者同意的情况下处理可识别患者身份的数据时的法律和伦理考量:从建立疾病登记册中汲取的经验教训
J Med Ethics. 2007 May;33(5):302-7. doi: 10.1136/jme.2006.016907.
6
Practice brief. Consent for the use or disclosure of individually identifiable health information.实践简报。关于使用或披露可识别个人身份的健康信息的同意书。
J AHIMA. 2001 May;72(5):suppl 64E-64G.
7
Learning from experience: privacy and the secondary use of data in health research.从经验中学习:健康研究中的隐私与数据二次使用
J Health Serv Res Policy. 2003 Jul;8 Suppl 1:S1:2-7. doi: 10.1258/135581903766468800.
8
Health information: reconciling personal privacy with the public good of human health.健康信息:平衡个人隐私与人类健康的公共利益。
Health Care Anal. 2001;9(3):321-35. doi: 10.1023/A:1012905932744.
9
HIPAA standards for privacy of individually identifiable health information: an introduction to the consent debate.《健康保险流通与责任法案》中关于可识别个人健康信息隐私的标准:同意问题辩论介绍
J Health Law. 2002 Summer;35(3):387-94.
10
Point-counterpoint. HIPAA privacy: what is the dilemma?针锋相对。《健康保险流通与责任法案》隐私条款:困境何在?
Physician Exec. 2004 Jan-Feb;30(1):35, 39-40.

引用本文的文献

1
Saudi views on consenting for research on medical records and leftover tissue samples.沙特对医疗记录和剩余组织样本研究的同意意见。
BMC Med Ethics. 2010 Oct 18;11:18. doi: 10.1186/1472-6939-11-18.
2
Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.在未获得知情同意的情况下使用常规收集的可识别健康信息进行的低风险研究:与患者信息咨询小组的接触
J Med Ethics. 2008 Jan;34(1):37-40. doi: 10.1136/jme.2006.019661.
3
Extracting information from hospital records: what patients think about consent.
从医院记录中提取信息:患者对同意的看法。
Qual Saf Health Care. 2007 Dec;16(6):404-8. doi: 10.1136/qshc.2006.020313.
4
National survey of British public's views on use of identifiable medical data by the National Cancer Registry.英国公众对国家癌症登记处使用可识别医疗数据看法的全国性调查。
BMJ. 2006 May 6;332(7549):1068-72. doi: 10.1136/bmj.38805.473738.7C. Epub 2006 Apr 28.
5
Legal aspects of records based medical research.基于记录的医学研究的法律问题。
Arch Dis Child. 2004 Oct;89(10):899-901. doi: 10.1136/adc.2003.045666.
6
Cross sectional survey of multicentre clinical databases in the United Kingdom.英国多中心临床数据库的横断面调查。
BMJ. 2004 Jun 19;328(7454):1478. doi: 10.1136/bmj.328.7454.1478.